Cause IQ organization profile

International Vaccine Institute (IVI)

Program areas | Form 990s | Financials | Vendors | Personnel | Peers

IVI is a international development organization based in Korea that was founded in 1997. As of 2019 they had $30 million in revenue and $21 million in assets.

The mission of International Vaccine Institute is to discover, develop, and deliver safe, effective and affordable vaccines for global public health.

EIN:
31-1621592
City:
Snu Research Park 1 Gwanak-Ro
State:
Korea
Website:
Phone:
82-2-872-2801
Facebook:
Twitter:
Founded:
1997
Type:
501(c)(3)
NTEE:
Revenue:
$30,266,811
Assets:
$21,208,830
Employees:
1
Fiscal year end:
December
Revenue trends:
Asset trends:

Program areas at IVI

Mers-cov Vaccine development against mers-cov since ivi launched the mers program in late 2015 with funding from the samsung life public welfare foundation, ivi continues to work on accelerating the development of mers vaccines, with the aim of demonstrating the safety and immunogenicity of two mers vaccines in phase ii trials conducted in south korea. With ind approval by the korean of food and drug stfety (kefds) in 2017, ivi and and geneone life sciences continued collaboration on conducting the phase i/iia clinical trials of geneone's mers dna Vaccine candidate in late 2018. Upon completion of the new toxicity study,required by kmfds as part of their ind approval,the trial initiated in september 2018, targeting completion of subject enrollment by january 2019. Ivi also kept engaging with a donor and Vaccine developers to select 2nd candidate mers-cov Vaccine in addition to geneone dna Vaccine, through landscape analysis. In 2018, ivi was ...

Vi-DT clinical developmnet support for SK VI-DT CLINICAL DEVELOPMENT SUPPORT FOR SK CHEMICALS WE DEVELOPED A TYPHOID CONJUGATE VACCINE USING PLATFORM TECHNOLOGY FROM THE U.S. NATIONAL INSTITUTES OF HEALTH, CONJUGATING THE SALMONELLA TYPHI VI POLYSACCHARIDE TO DIPHTHERIA TOXOID (VI-DT). CONJUGATE VACCINES HAVE THE ADVANTAGE OF CONFERRING PROTECTION TO INFANTS (A HIGH-RISK GROUP) AGAINST TYPHOID AS WELL AS GENERATING T-CELL-BASED IMMUNE RESPONSES. IVI TRANSFERRED THIS TECHNOLOGY TO SK CHEMICALS IN SOUTH KOREA IN 2013 AND RECEIVED GRANTS FROM THE GATES FOUNDATION TO WORK WITH SK CHEMICALS (IVI IS LEADING CLINICAL DEVELOPMENT). THIS COLLABORATION AIMS TO OBTAIN VACCINE LICENSURE AND THEN RECEIVE WHO PREQUALIFICATION FOR PROCUREMENT IN THE GAVI/ UNICEF MARKET. - PHASE I CLINICAL TRIAL FOR SK VI-DT WAS COMPLETED IN MANILA, THE PHILIPPINES. THERE WERE 144 STUDY PARTICIPANTS ENROLLED. THE TRIAL SHOWED NO VACCINE SAFETY CONCERNS AND A 100% SEROCONVERSION RATE. - PHASE II CLINICAL TRIALS IS IN PROGRESS IN ...

Seta severe typhoid in africa(seta) seta is a follow-up grant of tsap funded by the bill and melinda gates foundation. It aims to estimate the burden, severity, immune response, long-term sequelae and the associated costs of invasive salmonella infections in sub-saharan africa. Network of surveillance sites across 6 countries in ssa is set up and activities are on-going in all seta countries: madagascar (antananarivo, imerintsiatosika), burkina faso (ouagadougou, polesgo, nioko), ghana (agogo, kumasi), nigeria (ibadan), ethiopia (adama wenji and welayita sodo), and drc (kisantu.) As of december 31, 2018, a total of 318,076 patients had been screened from all participating sites. From these screened patients,12.5% (39,736/318,076) met the study inclusion criteria of which 40.6% (16,134/39,736) were enrolled in seta

Form 990s for IVI

Fiscal year endingDate received by IRSFormPDF link
2018-12Oct 12, 2019990View PDF
2017-12Oct 16, 2018990View PDF
2016-12Oct 12, 2017990View PDF
2015-12Nov 2, 2016990View PDF
2014-12Sep 17, 2015990View PDF
...and four more Form 990 PDFs

Financials for IVI

Field2018
Total grants, contributions, etc.$29,608,736
Program services$0
Investment income and dividends$185,544
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$-532
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$473,063
Total revenues$30,266,811

Vendors for IVI

VendorServicesAmount paidDate
PayPalFundraising software; Payment processing2020-09-05
█████████Content management system software2020-09-05
█████████ ████████Software2020-09-05
███ ███ ███Tax accounting2019-10-05
███ ██████ ██████████ █████ ███Consulting$490,0112018-12-01

Personnel at IVI

NameTitleCompensationMost recent data
Francois BelinDeputy Director General, Chief Operating Officer-July 12, 2020
Jerome H. KimDirector General$618,648July 12, 2020
███████ ██████████████Program Director , Typhoid$200,002Dec. 31, 2018
██████ ███████Head of Vaccine Process Dev$250,047Dec. 31, 2018
███ ████Head of Biostatistics and Data$223,113Dec. 31, 2018
█████ █████Deputy Dir Gen of Dev and Delvy$416,845Dec. 31, 2018
██████████ ███Deputy Dir Gen of Gov Affairs$218,773Dec. 31, 2018
████ ██████Deputy Dir Gen of Fin and Ops$338,472Dec. 31, 2018
██████ ██████Deputy Director of Finance and Op / Deputy Director General of Finance and Operations-Oct. 12, 2017
███████ ██████Acting Director of Dvi$251,030Dec. 31, 2014
...and six more key personnel

Peer international development and relief organizations

 NameTypeRevenueLocation
1Foundation for Innovative New Diagnostics (FIND)501(c)(3)$60 millionSwitzerland,
2International Crops Research Institute for the Semi-Arid Tropic (ICRISAT)501(c)(3)$72 millionIndia,
3AFRICAN Agricultural Technology FOUNDATION (AATF)501(c)(3)$22 millionKenya,
4Africa Rice Center501(c)(3)$17 millionCote D'ivoire (Ivory Coast),
5International Potato Center (CIP)501(c)(3)$69 millionPeru,
6International Institute of Tropical Agriculture (IITA)501(c)(3)$87 millionNiger,
7International Institute for Sustainable Development (IISD)501(c)(3)$18 millionCanada,
8The Asia Foundation501(c)(3)$105 millionSan Francisco, CA
9International Institute for Environment and Development (IIED)501(c)(3)$27 millionUnited Kingdom,
10IDEO org501(c)(3)$16 millionSan Francisco, CA
11Winrock International Institute for Agricultural Development501(c)(3)$105 millionLittle Rock, AR
12Miraclefeet501(c)(3)$7.6 millionChapel Hill, NC
13NetHope501(c)(3)$9.1 millionFairfax, VA
14Results for Development (R4D)501(c)(3)$19 millionWashington, DC
15Project HOPE501(c)(3)$89 millionMillwood, VA
16International Budget Partnership (IBP)501(c)(3)$19 millionWashington, DC
17Acdi / Voca501(c)(3)$98 millionWashington, DC
18Wateraid America501(c)(3)$14 millionNew York, NY
19Development Gateway501(c)(3)$8.9 millionWashington, DC
20Tides Center501(c)(3)$150 millionSan Francisco, CA
21Action Against Hunger USA501(c)(3)$146 millionNew York, NY
22Centro International de Agricultura Tropical (CIAT)501(c)(3)$85 millionMedley, FL
23International Partnership for Microbicides (IPM)501(c)(3)$35 millionSilver Spring, MD
24Aeras501(c)(3)$11 millionGermantown, MD
25C40 Cities Climate Leadership Group501(c)(3)$30 millionNew York, NY